Ignite Creation Date:
2025-12-24 @ 7:19 PM
Ignite Modification Date:
2026-02-02 @ 2:13 AM
Study NCT ID:
NCT02579603
Status:
COMPLETED
Last Update Posted:
2018-02-13
First Post:
2015-10-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability and PK of Nintedanib in Combination With Pirfenidone in IPF
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-10-16
Start Date Type:
ACTUAL
Primary Completion Date:
2017-01-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-01-31
Completion Date Type:
ACTUAL
First Submit Date:
2015-10-16
First Submit QC Date:
None
Study First Post Date:
2015-10-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-12-07
Results First Submit QC Date:
None
Results First Post Date:
2018-02-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-01-17
Last Update Post Date:
2018-02-13
Last Update Post Date Type:
ACTUAL